Zobrazeno 1 - 10
of 2 486
pro vyhledávání: '"Chibon, F"'
Autor:
Brahmi, M., Lesluyes, T., Dufresne, A., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Valentin, T., Chevreau, C., Bonvalot, S., Penel, N., Coindre, J.-M., Le Guellec, S., Le Loarer, F., Karanian, M., Blay, J.-Y., Chibon, F.
Publikováno v:
In ESMO Open February 2021 6(1)
Autor:
Manteaux G; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Amsel A; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Riquier-Morcant B; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Prieto Romero J; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Gayte L; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Fourneaux B; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Larroque M; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Gruel N; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, Institut Curie Research Center, Paris, France., Quignot C; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, Institut Curie Research Center, Paris, France., Perot G; INSERM UMR 1037, Centre de Recherche en Cancérologie de Toulouse, Université Paul Sabatier Toulouse-III, Toulouse, France., Jacq S; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Cisse MY; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Pomiès P; PhyMedExp, University of Montpellier-INSERM-CNRS, Montpellier, France., Sengenes C; RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France., Chibon F; INSERM UMR 1037, Centre de Recherche en Cancérologie de Toulouse, Université Paul Sabatier Toulouse-III, Toulouse, France., Heuillet M; Toulouse Biotechnologie Institute (TBI), Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.; MetaToul-MetaboHUB, National Infrastructure of Metabolomics and Fluxomics, Toulouse, France., Bellvert F; Toulouse Biotechnologie Institute (TBI), Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.; MetaToul-MetaboHUB, National Infrastructure of Metabolomics and Fluxomics, Toulouse, France., Watson S; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, Institut Curie Research Center, Paris, France.; Department of Medical Oncology, Institut Curie Hospital, Paris, France., Carrere S; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Firmin N; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Riscal R; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France. romain.riscal@inserm.fr., Linares LK; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France. laetitia.linares@inserm.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 12; Vol. 15 (1), pp. 7940. Date of Electronic Publication: 2024 Sep 12.
Autor:
Fontanges Q; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium.; Department of Pathology, Charleroi Hospital, Charleroi, Belgium.; Department of Pathology, Cliniques Universitaires de St Luc, Bruxelles, Belgique, Belgium., Dubos P; Department of Bioinformatics, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Lesluyes T; Oncosarc, INSERM UMR1037, Cancer Research Center, Toulouse, France., Laizet Y; Department of Bioinformatics, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Velasco V; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Meléndez B; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium., D'Haene N; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium., Oliva E; James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Young RH; James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mayeur L; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Rebier F; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Alamé M; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Larmonier C; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Devouassoux-Shisheboran M; Department of Pathology, CHU Lyon Sud, Pierrebenite, France., Arnould L; Department of Pathology, JF Leclerc Center, Comprehensive Cancer Center, Dijon, France., Soubeyran I; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Chakiba C; Department of Oncology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Floquet A; Department of Oncology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Babin G; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Guyon F; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Mery E; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Le Guellec S; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Noël JC; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium., Croce S; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; INSERM U1312 Sarcotarget, Bordeaux, France., Chibon F; Oncosarc, INSERM UMR1037, Cancer Research Center, Toulouse, France.; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
Publikováno v:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2024 Mar; Vol. 63 (3), pp. e23229.
Autor:
Ferron G; Surgical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France ferron.gwenael@iuct-oncopole.fr.; OncoSARC (Oncogenesis of Sarcoma), INSERM UMR1037, Toulouse, France., Bataillon G; Anatomopathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Martinez A; Surgical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.; T2i (Anti-tumour immunity and immunotherapy), INSERM UMR1037, Toulouse, France., Chibon F; OncoSARC (Oncogenesis of Sarcoma), INSERM UMR1037, Toulouse, France.; Surgical Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Valentin T; OncoSARC (Oncogenesis of Sarcoma), INSERM UMR1037, Toulouse, France.; Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Mar 04; Vol. 34 (3), pp. 393-402. Date of Electronic Publication: 2024 Mar 04.
Autor:
Brunac AC; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire (CHU), Toulouse, France., Fourquet J; Oncogenesis of Sarcomas, INSERM UMR1037, Cancer Research Centre of Toulouse, Toulouse, France., Perot G; Oncogenesis of Sarcomas, INSERM UMR1037, Cancer Research Centre of Toulouse, Toulouse, France., Jaffrelot M; Department of Digestive Oncology, Centre Hospitalier Universitaire (CHU), Toulouse, France., Meilleroux J; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire (CHU), Toulouse, France., Danjoux M; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire (CHU), Toulouse, France., Filleron T; Department of Biostatistics, Institut Claudius-Regaud, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France., Nicolaï V; Department of Medical Oncology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire (CHU), Toulouse, France., Guimbaud R; Department of Digestive Oncology, Centre Hospitalier Universitaire (CHU), Toulouse, France., Icher S; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire (CHU), Toulouse, France., Farés N; Department of Digestive Oncology, Centre Hospitalier Universitaire (CHU), Toulouse, France., Selves J; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire (CHU), Toulouse, France., Chibon F; Oncogenesis of Sarcomas, INSERM UMR1037, Cancer Research Centre of Toulouse, Toulouse, France. frederic.chibon@inserm.fr.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Dec; Vol. 35 (12), pp. 2002-2010. Date of Electronic Publication: 2022 Oct 06.
Autor:
Chakiba, C., Lagarde, P., Pissaloux, D., Neuville, A., Brulard, C., Pérot, G., Coindre, J.M., Terrier, P., Ranchere-Vince, D., Ferrari, A., Collini, P., Suurmeijer, A.J.H., Blay, J.Y., Terrisse, S.A., Piperno-Neumann, S., Averous, G., Bui, B., Orbach, D., Italiano, A., Chibon, F. *
Publikováno v:
In Annals of Oncology November 2014 25(11):2267-2271
Autor:
Poumeaud F; Department of Digestive Oncology, University Hospital of Toulouse (IUCT Rangueil Larrey), France; Department of Oncology, Toulouse Cancer Center (IUCT - Oncopole), France., Valentin T; Department of Oncology, Toulouse Cancer Center (IUCT - Oncopole), France; OncoSarc, INSERM U1037, Toulouse Cancer Research Center (CRCT), France., Vande Perre P; Department of Oncogenetic, Toulouse Cancer Center (IUCT - Oncopole), France., Jaffrelot M; Department of Digestive Oncology, University Hospital of Toulouse (IUCT Rangueil Larrey), France; Department of Oncogenetic, Toulouse Cancer Center (IUCT - Oncopole), France., Bonnet D; Department of Oncogenetic, Toulouse Cancer Center (IUCT - Oncopole), France; Department of Internal medicine and Immunology, University Hospital of Toulouse (IUCT Rangueil Larrey), France., Chibon F; OncoSarc, INSERM U1037, Toulouse Cancer Research Center (CRCT), France., Chevreau C; Department of Oncology, Toulouse Cancer Center (IUCT - Oncopole), France., Selves J; OncoSarc, INSERM U1037, Toulouse Cancer Research Center (CRCT), France; Department of Pathology, University Hospital of Toulouse (IUCT, Oncopole), France., Guimbaud R; Department of Digestive Oncology, University Hospital of Toulouse (IUCT Rangueil Larrey), France; OncoSarc, INSERM U1037, Toulouse Cancer Research Center (CRCT), France; Department of Oncogenetic, Toulouse Cancer Center (IUCT - Oncopole), France., Fares N; Department of Digestive Oncology, University Hospital of Toulouse (IUCT Rangueil Larrey), France; OncoSarc, INSERM U1037, Toulouse Cancer Research Center (CRCT), France. Electronic address: fares.n@chu-toulouse.fr.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Aug; Vol. 188, pp. 104055. Date of Electronic Publication: 2023 Jun 08.
Autor:
Feng X; Tom Baker Cancer Center, Department of Medical Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Tonon L; Synergie Lyon Cancer, Gille Thomas Bioinformatice Platform, Centre Léon Bérard, 69008 Lyon, France., Li H; Department of Mathematics and Statistics, University of Calgary, Calgary, AB T2N 4N1, Canada., Darbo E; BRIC, INSERM U1312, Université de Bordeaux, 33600 Bordeaux, France., Pleasance E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Macagno N; Department of Pathology, Aix Marseille University, INSERM, APHM MMG, UMR1251, Marmara Institute, La Timone Hospital, 13005 Marseille, France., Dufresne A; Department of Medical Oncology, Centre Leon Bérard, 69008 Lyon, France., Brahmi M; Department of Medical Oncology, Centre Leon Bérard, 69008 Lyon, France., Bollard J; Department of Medical Oncology, Centre Leon Bérard, 69008 Lyon, France., Ducimetière F; Department of Medical Oncology, Centre Leon Bérard, 69008 Lyon, France., Karanian M; Centre Léon Bérard, Department of Pathology, 69008 Lyon, France., Meurgey A; Centre Léon Bérard, Department of Pathology, 69008 Lyon, France., Pérot G; Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, 31000 Toulouse, France., Valentin T; Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, 31000 Toulouse, France., Chibon F; Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, 31000 Toulouse, France., Blay JY; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard Lyon, 69008 Lyon, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jul 21; Vol. 15 (14). Date of Electronic Publication: 2023 Jul 21.
Autor:
Michot A; Bordeaux Institute of Oncology, BRIC U1312, INSERM, 33000 Bordeaux, France.; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France.; Department of Biopathology, Bergonié Institute, Université Victor Segalen Site Carreire, Bordeaux 2, 33076 Bordeaux, France., Lagarde P; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France.; Department of Biopathology, Bergonié Institute, Université Victor Segalen Site Carreire, Bordeaux 2, 33076 Bordeaux, France., Lesluyes T; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France., Darbo E; Bordeaux Institute of Oncology, BRIC U1312, INSERM, 33000 Bordeaux, France.; Department of Biopathology, Bergonié Institute, Université Victor Segalen Site Carreire, Bordeaux 2, 33076 Bordeaux, France., Neuville A; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France., Baud J; Bordeaux Institute of Oncology, BRIC U1312, INSERM, 33000 Bordeaux, France., Perot G; OncoSarc, INSERM U1037, Cancer Research Center in Toulouse (CRCT), 31000 Toulouse, France.; Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, 31000 Toulouse, France., Bonomo I; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France., Maire M; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France., Michot M; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France., Coindre JM; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France.; Department of Biopathology, Bergonié Institute, Université Victor Segalen Site Carreire, Bordeaux 2, 33076 Bordeaux, France., Le Loarer F; Bordeaux Institute of Oncology, BRIC U1312, INSERM, 33000 Bordeaux, France.; Institut Bergonié, Centre de Lutte Contre le Cancer de Bordeaux, 33076 Bordeaux, France.; Department of Biopathology, Bergonié Institute, Université Victor Segalen Site Carreire, Bordeaux 2, 33076 Bordeaux, France., Chibon F; OncoSarc, INSERM U1037, Cancer Research Center in Toulouse (CRCT), 31000 Toulouse, France.; Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, 31000 Toulouse, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jun 30; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 30.
Autor:
Croce S; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; INSERM U1218, Bordeaux, France., Chibon F; Oncosarc, INSERM UMR1037, Cancer Research Center of Toulouse, Toulouse, France.; Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, Toulouse, France.
Publikováno v:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2021 Mar; Vol. 60 (3), pp. 129-137. Date of Electronic Publication: 2020 Nov 11.